Profitelligence Profitelligence · Filing Ledger Sign up free →

24 filings · most recent first

BABA Form 4 Insider Filings

Over the trailing 90 days, BABA insiders sold a net $45.1M in discretionary open-market trades (5 sellers), across 47 Form 4 transactions by 7 insiders.

Wu Yongming Files Alibaba Group Holding Limited Sp Adr Baba Form 4 September 10 Tsai Joseph C Files Alibaba Group Holding Limited Sp Adr Baba Form 4 August 25 Tsai Joseph C Files Alibaba Group Holding Limited Sp Adr Baba Form 4 August 24 Wu Yongming Files Alibaba Group Holding Limited Sp Adr Baba Form 4 August 24 Tsai Joseph C Files Alibaba Group Holding Ltd Baba Form 4 July 01 2026 Wu Yongming Files Alibaba Group Holding Ltd Baba Form 4 July 01 2026 Evans J Michael Files Alibaba Group Holding Ltd Baba Form 4 June 29 2026 Jiang Fan Fj Files Alibaba Group Holding Ltd Baba Form 4 June 25 2026 Xu Hong Files Alibaba Group Holding Ltd Baba Form 4 June 25 2026 Yu Siying Files Alibaba Group Holding Ltd Baba Form 4 June 25 2026 Jiang Fang Files Alibaba Group Holding Ltd Baba Form 4 June 25 2026 Wu Yongming Files Alibaba Group Holding Ltd Baba Form 4 May 29 2026 Jiang Fang Files Alibaba Group Holding Ltd Baba Form 4 May 29 2026 Jiang Fan Fj Files Alibaba Group Holding Ltd Baba Form 4 May 29 2026 Tsai Joseph C Files Alibaba Group Holding Ltd Baba Form 4 May 29 2026 Xu Hong Files Alibaba Group Holding Ltd Baba Form 4 May 29 2026 Yu Siying Files Alibaba Group Holding Ltd Baba Form 4 May 29 2026 Evans J Michael Files Alibaba Group Holding Ltd Baba Form 4 April 01 2026 Tsai Joseph C Files Alibaba Group Holding Ltd Baba Form 4 April 01 2026 Wu Maggie Wei Files Alibaba Group Holding Ltd Baba Form 4 April 01 2026 Wu Yongming Files Alibaba Group Holding Ltd Baba Form 4 April 01 2026 Jiang Fang Files Alibaba Group Holding Ltd Baba Form 4 March 25 2026 Xu Hong Files Alibaba Group Holding Ltd Baba Form 4 March 25 2026 Yu Siying Files Alibaba Group Holding Ltd Baba Form 4 March 25 2026

Most Active Insiders (Trailing 90 Days)

Detected Clusters

BABA full research: price, insiders, financials →